The Medicine Accelerator Recognised as BioPharma Company of the Year

APC & VLE Therapeutics have been recognised as BioPharma Company of the Year at the BioPharmaChem Ireland Impact Awards.

This recognition is an important milestone for The Medicine Accelerator. It reflects the work being done across APC and VLE Therapeutics to help bring more confidence, speed, and scientific depth to medicine development and manufacturing.

It also reflects something bigger: the strength of Ireland’s life sciences sector and the role Irish-led innovation can play in improving outcomes for patients around the world.

Irish science with global reach

Ireland has become one of the world’s most important locations for pharmaceutical development and manufacturing. The sector is home to global pharma companies, specialist technology providers, world-class manufacturing sites, and a deep base of scientific and engineering talent.

As an Irish multinational, The Medicine Accelerator is proud to be part of that ecosystem.

Through APC and VLE Therapeutics, we support clients across the medicine lifecycle, from complex process development and characterization through to GMP clinical manufacturing. Our work is grounded in process science, analytical expertise, digital CMC tools, and a strong understanding of what it takes to move a medicine from development toward manufacture.

The BioPharma Company of the Year recognition is a meaningful signal of the impact this model is having.

What this recognition reflects

For us, this award is not only about company growth. It is about the people, capabilities, and partnerships that make that growth possible.

It reflects the scientists, engineers, analysts, manufacturing teams, digital specialists, project leaders, and support functions who work every day to solve complex development challenges.

It reflects the collaboration between APC and VLE Therapeutics, where development insight, digital tools, and GMP manufacturing experience can be brought together earlier in the process.

And it reflects the trust of our clients and partners, who work with us on technically demanding programs where the quality of the science matters.

Built on science, digital, and GMP readiness

Medicine development is becoming more complex. New modalities, compressed timelines, evolving regulatory expectations, and increased pressure on manufacturing networks are changing what companies need from their development partners.

Strong execution is still essential, but it is no longer enough on its own.

Teams need better process understanding. They need data that can be interpreted and reused. They need development decisions that hold up during scale-up, transfer, and GMP manufacturing. And they need partners who can connect scientific depth with practical delivery.

This is where The Medicine Accelerator model is focused.

APC brings deep process development, characterization, scale-up, and transfer-ready CMC expertise. VLE Therapeutics brings GMP clinical manufacturing capability and a strong focus on regulatory and operational readiness. Together, the two organizations help clients move from complex development questions toward more confident manufacturing outcomes.

That work is also supported by digital CMC tools, including iAchieve®, which help structure knowledge, capture development rationale, and make scientific data more findable, usable, and connected across programs.

Recognition for the teams behind the work

Awards are valuable because they create a moment to pause and recognise progress. But the real work happens every day, across project teams, labs, manufacturing environments, digital systems, client meetings, and technical reviews.

This recognition belongs to the people behind that work.

It belongs to the teams who challenge assumptions, troubleshoot complex problems, build better processes, and keep patient impact in view. It belongs to our collaborators and partners who continue to push what is possible in medicine development. And it belongs to the wider Irish life sciences community, whose strength continues to shape global biopharma innovation.

Looking ahead

Being named BioPharma Company of the Year is a proud moment for APC, VLE Therapeutics, and The Medicine Accelerator.

It is also a reminder of the responsibility that comes with growth: to keep raising the standard for process science, digital CMC, GMP readiness, and partnership in medicine development.

We are grateful to BioPharmaChem Ireland, Enterprise Ireland, and the Impact Awards for this recognition.

Most importantly, we are grateful to our teams, clients, partners, and collaborators who make this work possible every day.